Contact
searchSearch
HMP Global
Login

Business

hands shake
Business
Details business of pathways, including, but not limited to financing and payment incentives, HEOR, predictable cost of care (PCOC), and cost modeling.

Transformative Business Trends
The Next Evolution of Employer Health Plans
10/16/2026
F. Randy Vogenberg, PhD, FASHP
This column examines how artificial intelligence, real-time analytics, and adaptive clinical pathways could shape 2027 benefit planning and simplify prior authorization.
This column examines how artificial intelligence, real-time analytics, and adaptive clinical pathways could shape 2027 benefit planning and simplify prior authorization.
This column examines how...
10/16/2026
Journal of Clinical Pathways
Transformative Business Trends
Medical Appropriateness and the Economics of Clinical Pathways
10/16/2026
F. Randy Vogenberg, PhD, FASHP
This column explores how clinical guidelines and pathways have evolved to support medical appropriateness, balance financial responsibility, and address growing challenges in health care access and affordability.
This column explores how clinical guidelines and pathways have evolved to support medical appropriateness, balance financial responsibility, and address growing challenges in health care access and affordability.
This column explores how...
10/16/2026
Journal of Clinical Pathways
Pharma Insights
Preparing for Oncology Pathway Placement Before and After Drug Launch
10/15/2026
Gordon Kuntz
This column explores how pharmaceutical manufacturers can incorporate clinical pathway strategies into oncology drug launch planning to improve treatment access and support preferred pathway placement.
This column explores how pharmaceutical manufacturers can incorporate clinical pathway strategies into oncology drug launch planning to improve treatment access and support preferred pathway placement.
This column explores how...
10/15/2026
Journal of Clinical Pathways
COA Viewpoint
What Survival Outcomes Reveal: New Evidence on Outcomes in Community Oncology
10/15/2026
Nicolas Ferreyros
This column highlights new real-world evidence linking independent community oncology care to favorable survival outcomes, emphasizing the importance of measuring quality and value beyond treatment costs.
This column highlights new real-world evidence linking independent community oncology care to favorable survival outcomes, emphasizing the importance of measuring quality and value beyond treatment costs.
This column highlights new...
10/15/2026
Journal of Clinical Pathways
Perspectives
Payer-Led Clinical Pathways in Oncology: A Case Study in Unintended Consequences
06/26/2026
Andrew D. Norden, MD, MBA, MPH
Oncology pathways have reduced some variation in care, but growing evidence suggests that proprietary pathway programs may now be contributing to administrative burden and fragmentation, prompting a reexamination of how payers and providers...
Oncology pathways have reduced some variation in care, but growing evidence suggests that proprietary pathway programs may now be contributing to administrative burden and fragmentation, prompting a reexamination of how payers and providers...
Oncology pathways have reduced...
06/26/2026
Journal of Clinical Pathways
Transformative Business Trends
Clinical Pathways at the Crossroads of AI and Value-Based Care
06/26/2026
F. Randy Vogenberg, PhD, FASHP
This column explores how AI is redefining clinical pathways, offering new opportunities to improve patient care, control costs, and address the structural challenges facing today's health care system.
This column explores how AI is redefining clinical pathways, offering new opportunities to improve patient care, control costs, and address the structural challenges facing today's health care system.
This column explores how AI is...
06/26/2026
Journal of Clinical Pathways
From the Field
Shining a Light on Payer Management in Medical-Benefit Oncology: A Call for Action to Prioritize Patient Care
04/18/2026
Lucio Gordan, MD; Kiana Mehring, MBA, PPMC; David T. Wenk, MD; Josh Eaves; Ryan Ciarrocchi
This study reveals how increasing payer control over oncology treatments is driving delays and administrative burden, undermining evidence-based, physician-led care and timely patient access.
This study reveals how increasing payer control over oncology treatments is driving delays and administrative burden, undermining evidence-based, physician-led care and timely patient access.
This study reveals how...
04/18/2026
Journal of Clinical Pathways
Transformative Business Trends
Navigating the Turns: Steering Health Benefits Through Economic and Clinical Transitions
04/16/2026
F. Randy Vogenberg, PhD, FASHP
As double-digit cost increases collide with economic uncertainty, employers are turning to data-driven clinical pathways to better control spending, improve outcomes, and shape more targeted health benefits for 2027.
As double-digit cost increases collide with economic uncertainty, employers are turning to data-driven clinical pathways to better control spending, improve outcomes, and shape more targeted health benefits for 2027.
As double-digit cost increases...
04/16/2026
Journal of Clinical Pathways
ONLINE EXCLUSIVES
Episode 5: PBMs, Part D, and Pathways—Who Really Controls Oncology Access?
04/08/2026
Gordon Kuntz; Bryan Loy, MD, MBA
In this episode of The Pathways Guys Podcast, our hosts cover Medicare Part D formularies in oncology, explaining how pharmacy benefit managers design drug coverage and how this impacts oncology market access, reimbursement, and patient care.
In this episode of The Pathways Guys Podcast, our hosts cover Medicare Part D formularies in oncology, explaining how pharmacy benefit managers design drug coverage and how this impacts oncology market access, reimbursement, and patient care.
In this episode of The Pathways...
04/08/2026
Journal of Clinical Pathways
ONLINE EXCLUSIVES
Why Payers Have Pathways—and What “Quality Care” Really Means
02/10/2026
Gordon Kuntz; Bryan Loy, MD, MBA
This Online Exclusive features the debut episode of The Pathways Guys podcast, a series exploring the real-world impact of clinical pathways on oncology policy, payment, and practice.
This Online Exclusive features the debut episode of The Pathways Guys podcast, a series exploring the real-world impact of clinical pathways on oncology policy, payment, and practice.
This Online Exclusive features...
02/10/2026
Journal of Clinical Pathways

Current Issue

October 2026
Volume 12
Issue 4-5
Current Issue
Issue Archive

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use